Measuring Vertebral Arteries Can Clarify Pathology of Transient Vascular Vertigo

TUESDAY, Nov. 22, 2022 (HealthDay News) -- Measuring vertebral arteries (VAs) using color-coded ultrasonography and cervical vestibular-evoked myogenic potential (cVEMP) can help to clarify the pathophysiology of transient vascular vertigo/dizziness (TVV), according to a study published online Nov. 11 in Acta Oto-Laryngologica.
Takaki Inui, from Osaka Medical and Pharmaceutical University in Japan, and colleagues clarified the pathophysiology of TVV in 10 TVV patients with central nervous system symptoms (TVVw) and 12 TVV patients without central nervous system symptoms (TVVo). Participants underwent duplex color-coded ultrasonographic evaluation of VAs, caloric tests, and cVEMP.
The researchers found that in TVVw versus TVVo, the mean flow velocity (MV) ratio (peak of MV of contralateral VA divided by target VA) was significantly higher. The occurrence of canal paresis did not differ between TVVw and TVVo. In TVVo cases only (six of 12), abnormal asymmetry ratios of cVEMP were observed, revealing a significant difference in the number of cases between TVVw and TVVo.
"Measuring the blood flow velocity and diameter of the VAs using duplex color-coded ultrasonography may help evaluate TVV," the authors write. "The different results of vestibular examinations are worth discussing, which may indicate a pathological distinction between TVVw and TVVo."
Abstract/Full Text (subscription or payment may be required)
Related Posts
ASA: Endovascular Therapy Studied in Large Ischemic Stroke
THURSDAY, Feb. 16, 2022 (HealthDay News) -- Patients with large cerebral vessel...
Women Face Higher Odds of Depression After Head Injury Than Men
TUESDAY, Oct. 17, 2023 (HealthDay News) -- Women are more likely to develop...
Workplace Fumes, Dust Could Raise Odds for Rheumatoid Arthritis
FRIDAY, Dec. 9, 2022 (HealthDay News) -- The air where you work could be...
Antiseptics Work Equally Well in Preventing Infection After Surgery for Open Fractures
WEDNESDAY, Nov. 2, 2022 (HealthDay News) -- Both 10 percent povidone-iodine and...